▮ Entertainment

Top Stories
Slide Shows
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ More

Wall Street Events

Plus

Neg

Email

EMagin Q3 19 Earnings Conference Call 9:00 AM ET

By RTTNews Staff Writer ✉ | Published: 11/7/2019 8:00 AM ET

eMagin Corp. (EMAN) will host a conference call at 9:00 AM ET on November 7, 2019, to discuss Q3 19 earnings results.

To access the live webcast, log on to ir.emagin.com

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In July 2020 Virtual Meetings Pandemic Rare Diseases colonoscopy and bronchoscopy

Biotech Stocks Facing FDA Decision In July 2020

New Drugs Approved In May

New Drugs Approved In May

Biotech Stocks Facing FDA Decision In June 2020 COVID19 papulopustular rosacea pneumonia NASH NMOSD Keytruda follicular lymphoma

Biotech Stocks Facing FDA Decision In June 2020

Latest Updates on COVID-19

Sanofi, Regeneron Stop Kevzara COVID-19 Trial In U.S. After Failing To Meet Key Goals

EU Gives Conditional Market Authorization For Gilead's Remdesivir Treat COVID-19

U.S. Secures Most Of Remdesivir Supply Till September

Pfizer And BioNTech' Potential Covid-19 Vaccine Shows Positive Data In Human Trial

COVID-19 Infections At Highest Level In US

Countries that tamed coronavirus

Read More

COVID-19: Drugs in Development

RELATED NEWS

Pre-Market Alert: EMagin Shares Soar 100% On $5.5 Mln DoD Award

Emagin Q1 Loss Narrows; Sees Higher Product Revenue In Q2

EARNINGS SUMMARY: Details of eMagin Corp. Q1 Earnings Report

Follow RTT

Editor's Pick
Most Read
Most Emailed

Polaris Recalls Ranger And General Utility, All-Terrain Vehicles

EU Gives Conditional Market Authorization For Gilead's Remdesivir Treat COVID-19

FedEx Asks Washington Redskins Team To Change Name

Cottage Town Bedroom Furniture Collection Recalled For Lead Concerns

Sanofi, Regeneron Stop Kevzara COVID-19 Trial In U.S. After Failing To Meet Key Goals

Moderna Reportedly Delays Phase 3 Trial Of COVID-19 Vaccine

Apple, Amazon, Facebook, Google CEOs Agree To Testify Before Congress

National Restaurant Association, ServSafe's Campaign To Project Healthy And Safe Restaurants

Tesla Deliveries About 90,650 Vehicles In Q2 - Quick Facts

Boy Scouts Of America Recalls Cub Scout Activity Pins

McDonald's Halts U.S. Reopening Plans

U.S. Secures Most Of Remdesivir Supply Till September

Meggitt Sells Meggitt Training Systems To Pine Island Capital For $146 Mln

LMNL Joins COVID-19 Battle, PFE/BNTX Vaccine Data Promising, EVLO On Watch

Pfizer And BioNTech' Potential Covid-19 Vaccine Shows Positive Data In Human Trial

Accolade To Debut On Nasdaq On July 2

After Market Hours: Akero Therapeutics, FedEx, Carver Bancorp Jump; Chiasma, Steelcase Slip

AKRO Soars After-hrs, ATHE On Watch, INO Reports COVID-19 Vaccine Trial Data, ZYNE Down But Not Out

IMMU Continues Ascent, IDXG On Fire, REGN's Kevzara Disappoints In COVID-19 Trial, BLFS On Watch

Stock Alert: Opes Acquisition Ascends 6%

Moderna Reportedly Delays Phase 3 Trial Of COVID-19 Vaccine

FTC Refunding Victims Of Fake Work-from-home Scheme

Stock Alert: AdaptHealth Trading 8% Higher

AES To Sell Itabo Power Plant To Grupo Linda For $110 Mln - Quick Facts

Wizz Air June Traffic, Load Factor Drop Sharply - Quick Facts

PG&E Emerges From Bankruptcy

DURECT Begins Patient Recruitment In Phase 2 Study Of DUR-928 In COVID-19 Patients

Schnitzer Steel Expects To Report Results In Single Operating Segment In Q1 2021

United Airlines To Triple Flights In August Despite Rise In COVID-19 Cases

Allianz Global Corporate & Specialty Announces Transformation Program

Dr. Reddy's Partners With FUJIFILM, Global Response Aid For Avigan Tablets - Quick Facts

Stock Alert: Blink Charging Jumps To New 52-week High

Stock Alert: Oxbridge Re Holdings Surges 45%

InterContinental Hotels Projects Q2 Comparable RevPAR Decline Of Approx. 75%

Smiths Group 10-month Underlying Revenue From Cont. Ops. Up 2% - Quick Facts

Standard Life Aberdeen Appoints Stephen Bird To Succeed Keith Skeoch As CEO